The Division of Vascular Surgery is actively engaged in both clinical and basic research. This research relies on a multidisciplinary approach to vascular disease and includes professors, fellows, residents, graduate students, postdoctoral fellows and medical students.
The Division’s research laboratories are located in the new Clark Center and are an integral part of the Stanford Bio-X Program, which joins together interdisciplinary basic research programs intersecting with clinical research.
In summary, our mission is to provide a model of clinical and scientific excellence in the diagnosis and treatment of vascular diseases, to deliver the highest quality of care to our patients by a team of dedicated surgeons and nurses, and to achieve these goals within an environment that fosters compassion and respects the humanity of the individual person.
Dr. Leeper, President of the Silicon Valley American Heart Association Board and Assistant Professor of Vascular Surgery, discusses the importance of AHA funding for cardiovascular research.
Vascular Surgery Research Programs
- Ronald L. Dalman, MD - Pathogenesis of abdominal aortic aneurysms
- Jason T. Lee, M.D. - Stenting and Angioplasty with Protection in Patients at High-Risk for Endartecrectomy / Cordis
- Nicholas Leeper, M.D. - Genetics and vascular biology of atherosclerosis
- Christopher P. Cheng, Ph.D. - Biomechanical interactions between the dynamic cardiovascular system and medical devices
- Endovascular stent-graft repair of abdominal and thoracic aortic aneurysms
- Prognostic indicators of outcome following open repair of thoracic and abdominal aneurysms
- Development of optimal techniques for 3-dimensional color-flow duplex ultrasound of the abdominal aorta, visceral and carotid arteries
- Evaluation of efficacy of carotid artery stenting in comparison to carotid endarterectomy
- QA mechanisms to improve outcome and reduce cost of carotid endarterectomy
- Vascular injuries in athletes
- Optimal management of thoracic outlet syndromes
- Surgical approaches to complex renovascular disease
- Outcome analysis and cost effectiveness of new vascular technologies
- Optimal care of peripheral occlusive disease